Summary This article explores the latest breakthroughs in understanding insulin resistance, a critical factor in diabetes and other metabolic disorders. We delve into the intricate molecular mechanisms underlying this condition, highlighting promising new treatment avenues. […]
Summary Statins effectively lower cholesterol and cardiovascular risk in diabetes patients, but may slightly increase blood sugar. Benefits generally outweigh risks, making statins crucial for heart health in diabetes. This article explores statin use in […]
Summary This article explores the potential of intermittent fasting (IF) for achieving type 2 diabetes remission, particularly in real-world settings. It examines recent research and case studies highlighting the effectiveness of IF in improving glycemic […]
Summary Researchers have developed a groundbreaking vascularized model of stem cell-derived islet cells, offering new hope for diabetes treatment. This model mimics the natural environment of the pancreas more effectively than previous models, paving the […]
Summary Scientists have identified the PPP1R3B gene as a key regulator of how the liver stores energy, impacting metabolic disease risk. This discovery paves the way for personalized treatments for type 2 diabetes and fatty […]
Summary Researchers have identified a potential new treatment strategy for Type 1 diabetes by targeting the TYK2 protein, which plays a crucial role in inflammation. Blocking TYK2 not only protects insulin-producing beta cells in the […]
Summary This article explores the intricate relationship between obesity, beta-cell function, and colonic inflammation in the context of diabetes. It examines how obesity can lead to both increased and decreased beta-cell function, with colonic inflammation […]
Summary New research suggests a link between enteroviral infections and the development of type 1 diabetes (T1D). Studies reveal that persistent, low-level enteroviral infections in the pancreas may trigger an autoimmune attack on insulin-producing cells. […]
Summary The mylife CamAPS FX app, a hybrid closed-loop system for Type 1 diabetes management, is now available on iOS devices in the UK. This expansion offers greater choice and flexibility for individuals managing T1D. […]
Summary Teplizumab, the first drug to delay type 1 diabetes, offers new hope. It delays progression to stage 3 by approximately two years, giving patients valuable time before insulin dependence. This breakthrough paves the way […]
© 2026 Newsguru LTD. All rights reserved.